1[1]Adelstein DJ, Kalish LA, Adams GL, et al.Concurrent radiation therapy and chemotherapy for locally unresectable squamous cell head and neck cancer: an Eastern Cooperative Oncology Group pilot study [J]. J Clin Oncol, 1993, 11(11):2136-2142.
2[2]McGuir WP, Rowinsk EK, Rosenhein NB, et al.Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelia neoplasms [J]. Ann Intern Med,1989,111(1):273-279.
3[3]Holm FA, Walters RS, Thierault RL, et al.Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer [J]. J Natl Cancer Inst,1991,83(24):1797-1805.
4[4]Chang AY, Kim K, Glick J, et al.Phase II study of taxol, merbarone, and piroxantrone in stage IV non-small-cell lung cancer: an Eastern Cooperative Oncology Group pilot study [J]. J Natl Cancer Inst,1993,85(5):388-394.
5[5]Leonard CE, Chan DC, Chou TC, et al. Paclitaxel enhances in vitra radiation sensitivity of squamous carcinoma cell lines of the head neck [J]. Cancer Res,1996,56(22):5189-5204.
6[6]Milas L, Hunter NR, Mason KA, et al. Role of reoxygenation in induction of enhancement of tumor radioresponse by paclitaxel [J]. Cancer Res,1997,55(16):3564-3568.
7[7]Ajani JA, Ilson DH, Dougherty K, et al: Paclitaxel in the treatment of carcinoma of the esophagus [J]. Semin Oncol,1995,22(Suppl 6): 3540-3545.
8[8]Murphy WK, Fossella FV, Winn RJ, et al. Phase II study of taxol in patients with untreated advanced non-small-cell lung cancer [J]. J Natl Cancer Inst,1993,85(5):384-388.
9[9]Forastiere AA, Neuberg D, Taylor SG.Phase II evaluation of taxol in advanced head and neck cancer: an Eastern Cooperative Oncology Group pilot study [J]. J Natl Cancer Inst Monogr,1993,15(1):181-184.
10[10]Hoffmann W, Belka C, Schmidberger H, et al. Radiotherapy and concomitant weekly 1-hour infusion of paclitaxel in the treatment of head and neck cancer-results from a phase I trial [J]. Int J Radiat Oncol Biol Phys,1997,38(4): 691-696.
